VOR vs. ASST

Last updated Jun 13, 2026

VOR (Vor Biopharma Inc.) and ASST (Asset Entities Inc. Class B Common Stock) are both stocks. VOR operates in Biotechnology (Healthcare), while ASST operates in Internet Content & Information (Communication Services). Over the past 3 years, VOR returned -48.18%/yr vs -56.18%/yr for ASST. At a 0.03 correlation, their price movements are largely independent.

Performance

VOR vs. ASST - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vor Biopharma Inc. (VOR) and Asset Entities Inc. Class B Common Stock (ASST). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, VOR achieves a 9.79% return, which is significantly higher than ASST's 2.64% return.

VOR

• 1D: 1.92%
• 1M: -1.85%
• YTD: 9.79%
• 6M: 14.79%
• 1Y: 294.29%
• 3Y*: -48.18%
• 5Y*: -49.22%
• 10Y*: —

ASST

• 1D: 3.91%
• 1M: -9.77%
• YTD: 2.64%
• 6M: -12.25%
• 1Y: -86.92%
• 3Y*: -56.18%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

VOR vs. ASST - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
VOR Vor Biopharma Inc.	9.79%	-41.08%	-50.67%	-58.41%
ASST Asset Entities Inc. Class B Common Stock	2.64%	50.46%	-84.65%	-89.13%

Correlation

The correlation between VOR and ASST is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.12
Correlation (3Y) Calculated over the trailing 3-year period	0.02
Correlation (All Time) Calculated using the full available price history since Feb 3, 2023	0.03

The correlation between VOR and ASST shifts across timeframes, from 0.02 (3 years) to 0.12 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap VOR : $617.65M ASST : $933.69M
EPS VOR : -$53.66 ASST : -$25.54
Total Revenue (TTM) VOR : $0.00 ASST : $5.73M
Gross Profit (TTM) VOR : -$23.00K ASST : -$7.43M
EBITDA (TTM) VOR : -$1.13B ASST : -$304.63M

Return for Risk

VOR vs. ASST — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VOR

VOR Risk / Return Rank: 83
VOR Sharpe Ratio Rank: 82
VOR Sortino Ratio Rank: 90
VOR Omega Ratio Rank: 88
VOR Calmar Ratio Rank: 83
VOR Martin Ratio Rank: 73

ASST

ASST Risk / Return Rank: 15
ASST Sharpe Ratio Rank: 19
ASST Sortino Ratio Rank: 14
ASST Omega Ratio Rank: 17
ASST Calmar Ratio Rank: 6
ASST Martin Ratio Rank: 18

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VOR vs. ASST - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vor Biopharma Inc. (VOR) and Asset Entities Inc. Class B Common Stock (ASST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	VOR	ASST	Difference
Sharpe ratio: Return per unit of total volatility	1.45	-0.54	+1.99
Sortino ratio: Return per unit of downside risk	3.09	-0.86	+3.95
Omega ratio: Gain probability vs. loss probability	1.38	0.91	+0.47
Calmar ratio: Return relative to maximum drawdown	2.85	-0.92	+3.77
Martin ratio: Return relative to average drawdown	4.09	-1.12	+5.21

VOR vs. ASST - Sharpe Ratio Comparison

The current VOR Sharpe Ratio is 1.45, which is higher than the ASST Sharpe Ratio of -0.54. The chart below compares the historical Sharpe Ratios of VOR and ASST, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

VOR vs. ASST - Drawdown Comparison

The maximum VOR drawdown since its inception was -99.72%, roughly equal to the maximum ASST drawdown of -98.78%. Use the drawdown chart below to compare losses from any high point for VOR and ASST.

Drawdown Indicators

	VOR	ASST	Difference
Max Drawdown Largest peak-to-trough decline	-99.72%	-98.78%	-0.94%
Max Drawdown (1Y) Largest decline over 1 year	-87.15%	-95.98%	+8.83%
Max Drawdown (3Y) Largest decline over 3 years	-97.02%	-97.25%	+0.23%
Max Drawdown (5Y) Largest decline over 5 years	-99.29%	—	—
Current Drawdown Current decline from peak	-98.67%	-97.42%	-1.25%
Average Drawdown Average peak-to-trough decline	-88.69%	-90.39%	+1.70%
Ulcer Index Depth and duration of drawdowns from previous peaks	60.71%	78.47%	-17.76%

Volatility

VOR vs. ASST - Volatility Comparison

Vor Biopharma Inc. (VOR) and Asset Entities Inc. Class B Common Stock (ASST) have volatilities of 23.24% and 23.80%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	VOR	ASST	Difference
Volatility (1M) Calculated over the trailing 1-month period	23.24%	23.80%	-0.56%
Volatility (6M) Calculated over the trailing 6-month period	68.60%	81.69%	-13.09%
Volatility (1Y) Calculated over the trailing 1-year period	171.72%	162.68%	+9.04%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	116.35%	322.54%	-206.19%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	116.73%	322.54%	-205.81%

Dividends

VOR vs. ASST - Dividend Comparison

Neither VOR nor ASST has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both VOR and ASST in my portfolio?

VOR and ASST have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, VOR or ASST?

ASST has higher volatility (23.80%) compared to VOR (23.24%). In terms of maximum drawdown, VOR dropped -99.72% vs ASST's -98.78%.

Which has better risk-adjusted returns?

VOR currently has the higher Sharpe Ratio (1.45 vs -0.54), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.